Literature DB >> 34214497

Engineered Chitosan-based Nanoparticles Modulate Macrophage-Periodontal Ligament Fibroblast Interactions in Biofilm-mediated Inflammation.

Hebatullah Hussein1, Anil Kishen2.   

Abstract

INTRODUCTION: Crosstalk between immune cells and tissue-resident cells regulates the pathophysiology and posttreatment healing of apical periodontitis. This investigation aimed to understand the influence of residual root canal biofilm on macrophage (MQ)-periodontal ligament fibroblast (PdLF) interaction and evaluate the effect of engineered chitosan-based nanoparticles (CSnp) on MQ-PdLF interactions in residual biofilm-mediated inflammation.
METHODS: Six-week-old Enterococcus faecalis biofilms in root canal models were disinfected conventionally using sodium hypochlorite alone or followed by calcium hydroxide medication or CSnp dispersed in carboxymethylated chitosan (CMCS). The effect of the treated biofilms (n = 25/group) on the inflammatory response of THP-1-differentiated MQ monoculture versus coculture with PdLF was evaluated for cell viability, MQ morphometric characterization, inflammatory mediators (nitric oxide, tumor necrosis factor alpha, interleukin [IL]-1 beta, IL-1RA, IL-6, transforming growth factor beta 1 [TGF-β1], and IL-10), and the expression of transcription factors (pSTAT1/pSTAT6)/cluster of differentiation markers (CD80/206) after 24, 48, and 72 hours of interaction. PdLF transwell migration was evaluated after 8 and 24 hours. Unstimulated cells served as the negative control, whereas untreated biofilm was the positive control.
RESULTS: Biofilm increased nitric oxide and IL-1β but suppressed IL-10, IL-1RA, and PdLF migration with significant cytotoxic effects. CSnp/CMCS reduced nitric oxide and IL-1β (P < .01) while maintaining ≥90% cell survival up to 72 hours with evident M2-like MQ phenotypic changes in coculture. CSnp/CMCS also increased the IL-1RA/IL-1β ratio and enhanced TGF-β1 production over time (P < .05, 72 hours). In coculture, CSnp/CMCS showed the highest IL-10 level at 72 hours (P < .01), reduced the pSTAT1/pSTAT6 ratio, and enhanced PdLF migration (P < .01, 24 hours).
CONCLUSIONS: CSnp/CMCS medication facilitated MQ switch toward M2 (regulatory/anti-inflammatory) phenotype and PdLF migration via paracrine signaling.
Copyright © 2021 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biofilm; chitosan nanoparticles; immunomodulation; inflammation; macrophage polarization

Year:  2021        PMID: 34214497     DOI: 10.1016/j.joen.2021.06.017

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  5 in total

1.  Assessment of Physicochemical and In Vivo Biological Properties of Polymeric Nanocapsules Based on Chitosan and Poly(N-vinyl pyrrolidone-alt-itaconic anhydride).

Authors:  Kheira Zanoune Dellali; Mohammed Dellali; Delia Mihaela Raţă; Anca Niculina Cadinoiu; Leonard Ionut Atanase; Marcel Popa; Mihaela-Claudia Spataru; Carmen Solcan
Journal:  Polymers (Basel)       Date:  2022-04-28       Impact factor: 4.967

2.  Proteomic profiling reveals engineered chitosan nanoparticles mediated cellular crosstalk and immunomodulation for therapeutic application in apical periodontitis.

Authors:  Hebatullah Hussein; Anil Kishen
Journal:  Bioact Mater       Date:  2021-10-09

3.  Biomaterial scaffolds for clinical procedures in endodontic regeneration.

Authors:  He Liu; Jing Lu; Qianzhou Jiang; Markus Haapasalo; Junrong Qian; Franklin R Tay; Ya Shen
Journal:  Bioact Mater       Date:  2021-10-14

4.  Evaluation of the Chemical, Morphological, Physical, Mechanical, and Biological Properties of Chitosan/Polyvinyl Alcohol Nanofibrous Scaffolds for Potential Use in Oral Tissue Engineering.

Authors:  Gamil Al-Madhagy; Ibrahim Alghoraibi; Khaldoun Darwich; Mohammad Y Hajeer
Journal:  Cureus       Date:  2022-10-03

Review 5.  Antimicrobial and Antibiofilm Properties of Bioceramic Materials in Endodontics.

Authors:  Zhejun Wang; Ya Shen; Markus Haapasalo
Journal:  Materials (Basel)       Date:  2021-12-10       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.